PharmaBoardroom

India: Key Pricing & Reimbursement Developments in 2019

2019 so far has witnessed a lot of activity in the pharma space, so much so that the e-pharmacy saga – a pressing development towards the close of…

India: Key Healthcare Developments in 2019

The Indian Government has had a busy 2019 so far with respect to healthcare regulation. From passing the controversial National Medical Commission…

Gujarat: The Home of Indian Pharma

The state of Gujarat proudly stands as India’s main pharmaceutical hub, accounting for over 33 percent of the country’s pharmaceutical turnover…

Three Key Political Issues for Pharma: Protests, Pricing &…

This month, Aditya Bhattacharji takes stock of three political issues that are dominating Eurasia Group’s conversations with pharmaceutical firms:…

UAE: Making Strides Against Lifestyle Diseases

The UAE's rapid economic growth over the last half-century has been accompanied by a surge in lifestyle diseases such as diabetes and obesity. Both…

Pharma Faces: Vivek Sharma, PPS

Unlike many of his pharma peers, Vivek Sharma worked in operations and finance for two decades before joining the life sciences industry as head of…

Company Profile: Novo Nordisk Thailand

Every generation of Novo Nordisk’s insulin portfolio is currently on the Thai Market and the affiliate is one of the fastest-growing pharma…

Countering Algeria’s Diabetes Epidemic, With Pharmacists?

Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients' diabetes…

Valtero Canepa – General Manager, Bracco China

Valtero Canepa, general manager for China of Italian family-owned diagnostic imaging specialist Bracco, outlines the importance of China for the firm,…

Kit Tang – General Manager, Roche Diagnostics Taiwan

The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that…

Danny Liao – CEO, Skyla, Taiwan

Danny Liao, CEO of Taiwanese diagnostics firm Skyla discusses the reason behind splitting from parent company Lite-On, the thinking behind a move from…

Countering Korea’s Diabetes Epidemic, With AI?

Industry players - from Big Pharma giants to small local startups - are bringing new, innovative solutions to market in Korea in order to try and…

Tagged with DIA